Product Code: MD 3503
The global infection control market is projected to reach USD 77.67 billion by 2030 from USD 57.31 billion in 2025, at a CAGR of 6.3% during the forecast period.
| Scope of the Report |
| Years Considered for the Study | 2024-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD billion) |
| Segments | Products & Services and End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries |
The market is expected to experience high growth due to the high global prevalence of healthcare-associated infections (HAIs), a surge in surgeries, advancements in reprocessing technologies, a rising emphasis on the sterilization and disinfection of food, and improvements in sterilization equipment technology. Growing concerns about the safety of reprocessed instruments and the consequences associated with the use of chemical disinfectants will likely restrain market growth.
"The hospitals & clinics segment is expected to hold the largest position during the forecast period"
Based on end user, the market is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, the life sciences industry, and other end users. In 2024, hospitals & clinics accounted for the largest share of the market. The hospitals and clinics segment holds the largest share of the infection control market as these facilities operate continuously, manage high patient volumes, and conduct complex medical procedures, all of which heighten the risk of infection transmission. To ensure safe environments for patients and staff, they rely on strict hygiene, disinfection, and sterilization protocols. Moreover, compliance with regulatory requirements and the need to prevent costly infection outbreaks drive significant investment in infection prevention, making hospitals and clinics the leading end users of infection control solutions.
"Cleaning & disinfection products segment accounts for the largest market share in the infection control market"
The infection control market is segmented into sterilization products & services, cleaning & disinfection products, protective barriers, endoscope reprocessing products, and other infection control products, based on treatment. The cleaning & disinfection products segment accounted for the largest share of the market in 2024. Cleaning & disinfection products play a crucial role in infection control as they effectively remove harmful pathogens from surfaces, medical equipment, and environments, thereby reducing the risk of infection transmission. These products are essential for maintaining hygiene standards in hospitals, clinics, laboratories, and other healthcare facilities, thereby protecting patients and healthcare personnel. Their frequent use, wide range of applications, and essential function in interrupting the infection chain make them the most extensively utilized and indispensable segment of the infection control market.
"Asia Pacific is expected to be the fastest-growing market for infection control during the forecast period, while North America leads in the market size"
The global infection control market is segmented into six segments, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific is the fastest-growing region in the infection control market, driven by its rapidly expanding healthcare infrastructure, rising patient volumes, and increasing awareness of infection prevention. The region is experiencing significant growth in hospital construction, medical tourism, and healthcare investments, which drives the demand for sterilization, disinfection, and hygiene solutions. The increasing occurrence of healthcare-associated infections, along with the implementation of stricter regulatory standards, is driving hospitals and clinics to adopt more advanced infection control practices. Furthermore, government initiatives, the growth of pharmaceutical and medical device manufacturing, and a large population base are contributing to the robust market growth in the region.
North America leads the infection control market due to its well-established healthcare system, advanced technological infrastructure, and high adoption rates of innovative infection prevention solutions. The region benefits from significant investments in healthcare research and development, stringent regulatory frameworks enforced by agencies like the FDA, and a strong presence of leading market players. Rising healthcare expenditures, a high prevalence of hospital-acquired infections, and a focus on patient safety further bolster demand for sterilization and disinfection products. Additionally, the region's mature market dynamics, supported by extensive training programs and awareness campaigns, ensure a steady uptake of cutting-edge technologies, solidifying North America's dominant position in the global infection control market.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1: 55%, Tier 2: 30%, and Tier 3: 15%
- By Designation: C Level: 28%, Director Level: 43%, and Others: 39%
- By Region: North America: 35%, Europe: 20%, Asia Pacific: 30%, Latin America: 7%, Middle East & Africa: 5%, and GCC Countries: 3%
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the infection control market are STERIS (US), Reckitt Benckiser Group plc. (UK), Fortive (US), Sotera Health (US), and Solventum (US).
Research Coverage
This report examines the infection control market in terms of products & services, end-users, and regions. The report also examines key factors (including drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets in terms of their individual growth trends. It forecasts the revenue of the market segments with respect to six major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms and smaller entrants to gauge the market's pulse, which in turn will help them garner a larger market share. Firms purchasing the report could use one or more strategies mentioned below to strengthen their market presence.
This report provides insights into the following pointers:
Analysis of key Drivers (Rising prevalence of HAIs, increasing number of surgical procedures, Advancements in reprocessing technologies; Increasing emphasis on sterilization & disinfection of food; Advancements in sterilization equipment technology; Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals)
Restraints (Growing concerns about the safety of reprocessed instruments; Consequences associated with chemical disinfectant use; High cost of endoscopy reprocessing and limited reimbursements)
Opportunities (Increasing prevalence of medical devices and pharmaceutical companies in developing nations; Reintegration of ethylene oxide sterilization; Growing utilization of E-beam sterilization)
Challenges (Sterilization of advanced medical devices; Alternative methods for surface disinfection; Increasing adoption of single-use medical devices)
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the infection control market
Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the infection control market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the infection control market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players, such as STERIS (US), Reckitt Benckiser Group plc. (UK), Fortive (US), Sotera Health (US), and Solventum (US)
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key secondary sources
- 2.1.1.2 List of key secondary sources
- 2.1.1.3 Key data from secondary sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Key objectives of primary research
- 2.1.2.2 List of primary sources
- 2.1.2.3 Key data from primary sources
- 2.1.2.4 Breakdown of primary interviews
- 2.1.2.5 Insights from industry experts
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 BOTTOM-UP APPROACH
- 2.2.1.1 Revenue estimation of key players
- 2.2.1.2 Study of annual reports and investor presentations
- 2.2.1.3 Primary interviews
- 2.2.1.4 Growth forecast
- 2.2.1.5 CAGR projections
- 2.2.2 TOP-DOWN APPROACH
- 2.3 DATA TRIANGULATION
- 2.4 STUDY ASSUMPTIONS
- 2.4.1 RESEARCH-RELATED ASSUMPTIONS
- 2.4.2 PARAMETRIC ASSUMPTIONS
- 2.4.3 ASSUMPTIONS
- 2.5 RESEARCH LIMITATIONS
- 2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN INFECTION CONTROL MARKET
- 4.2 ASIA PACIFIC: INFECTION CONTROL MARKET, BY END USER AND COUNTRY
- 4.3 INFECTION CONTROL MARKET, BY COUNTRY
- 4.4 INFECTION CONTROL MARKET, BY REGION
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Rising prevalence of HAIs
- 5.2.1.2 Increasing number of surgical procedures
- 5.2.1.3 Advancements in reprocessing technologies
- 5.2.1.4 Increasing emphasis on sterilization & disinfection of food
- 5.2.1.5 Advancements in sterilization equipment technology
- 5.2.1.6 Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals
- 5.2.2 RESTRAINTS
- 5.2.2.1 Growing concerns about safety of reprocessed instruments
- 5.2.2.2 Consequences associated with chemical disinfectant use
- 5.2.2.3 High cost of endoscopy reprocessing and limited reimbursements
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Growing presence of medical device and pharmaceutical companies in developing nations
- 5.2.3.2 Reintegration of ethylene oxide sterilization
- 5.2.3.3 Growing utilization of E-beam sterilization
- 5.2.4 CHALLENGES
- 5.2.4.1 Sterilization of advanced medical devices
- 5.2.4.2 Alternative methods for surface disinfection
- 5.2.4.3 Increasing adoption of single-use medical devices
- 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.4 PRICING ANALYSIS
- 5.4.1 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS, BY TYPE, 2023-2025
- 5.4.2 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS, BY KEY PLAYER, 2023-2025
- 5.4.3 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS, BY REGION, 2023-2025
- 5.5 VALUE CHAIN ANALYSIS
- 5.6 SUPPLY CHAIN ANALYSIS
- 5.7 ECOSYSTEM ANALYSIS
- 5.8 INVESTMENT & FUNDING SCENARIO
- 5.9 TECHNOLOGY ANALYSIS
- 5.9.1 KEY TECHNOLOGIES
- 5.9.1.1 Heat sterilization
- 5.9.2 COMPLEMENTARY TECHNOLOGIES
- 5.9.2.1 Ultra-high-pressure sterilization
- 5.9.3 ADJACENT TECHNOLOGIES
- 5.9.3.1 Nitrogen dioxide (NO2)
- 5.10 PATENT ANALYSIS
- 5.10.1 LIST OF KEY PATENTS
- 5.11 TRADE ANALYSIS
- 5.11.1 IMPORT DATA FOR HS CODE 841920
- 5.11.2 EXPORT DATA FOR HS CODE 841920
- 5.12 KEY CONFERENCES & EVENTS, 2025-2026
- 5.13 CASE STUDY ANALYSIS
- 5.13.1 CASE STUDY 1: DILUTION DYSFUNCTION - EVALUATION OF AUTOMATED DISINFECTANT DISPENSER SYSTEMS IN 10 HOSPITALS
- 5.13.2 CASE STUDY 2: IMPLEMENTATION OF A NOVEL COLOR ADDITIVE FOR BLEACH DISINFECTANT WIPES ENHANCES CLEANING PERFORMANCE IN AN ACADEMIC MEDICAL CENTER
- 5.13.3 CASE STUDY 3: THE IMPACT OF ENHANCED CLEANING ON BACTERIAL CONTAMINATION OF HOSPITAL ENVIRONMENTAL SURFACES - A CLINICAL TRIAL IN CRITICAL CARE UNITS, EGYPT
- 5.14 REGULATORY ANALYSIS
- 5.14.1 REGULATORY LANDSCAPE
- 5.14.1.1 North America
- 5.14.1.1.1 US
- 5.14.1.1.2 Canada
- 5.14.1.2 Europe
- 5.14.1.3 Asia Pacific
- 5.14.1.3.1 Japan
- 5.14.1.3.2 China
- 5.14.1.3.3 Australia
- 5.14.1.4 Latin America
- 5.14.1.4.1 Brazil
- 5.14.1.4.2 Mexico
- 5.14.1.5 Middle East
- 5.14.1.6 Africa
- 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.15 PORTER'S FIVE FORCES ANALYSIS
- 5.15.1 BARGAINING POWER OF SUPPLIERS
- 5.15.2 BARGAINING POWER OF BUYERS
- 5.15.3 THREAT OF NEW ENTRANTS
- 5.15.4 THREAT OF SUBSTITUTES
- 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.16.2 KEY BUYING CRITERIA
- 5.17 IMPACT OF AI/GEN AI ON INFECTION CONTROL MARKET
- 5.17.1 INTRODUCTION
- 5.17.2 POTENTIAL OF AI
- 5.17.3 IMPACT OF AI
- 5.17.4 KEY COMPANIES IMPLEMENTING AI
- 5.17.5 FUTURE OF AI
- 5.18 IMPACT OF 2025 US TARIFFS ON INFECTION CONTROL MARKET
- 5.18.1 INTRODUCTION
- 5.18.2 KEY TARIFF RATES
- 5.18.3 PRICE IMPACT ANALYSIS
- 5.18.4 IMPACT ON COUNTRY/REGION
- 5.18.4.1 North America
- 5.18.4.2 Europe
- 5.18.4.3 Asia Pacific
- 5.18.5 IMPACT ON END-USE INDUSTRIES
- 5.18.5.1 Hospitals & clinics
- 5.18.5.2 Medical device companies
- 5.18.5.3 Pharmaceutical & life science industry
- 5.18.5.4 Food industry
6 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE
- 6.1 INTRODUCTION
- 6.2 STERILIZATION PRODUCTS & SERVICES
- 6.2.1 STERILIZATION EQUIPMENT
- 6.2.1.1 Heat sterilization equipment
- 6.2.1.1.1 Moist heat sterilizers
- 6.2.1.1.1.1 Versatility across material testing to fuel market growth
- 6.2.1.1.2 Dry heat sterilizers
- 6.2.1.1.2.1 Increasing demand for heat-sensitive instruments to boost demand
- 6.2.1.2 Low-temperature sterilization equipment
- 6.2.1.2.1 Hydrogen peroxide sterilizers
- 6.2.1.2.1.1 Effective application across broad industries to fuel market
- 6.2.1.2.2 Ethylene oxide (EtO) sterilizers
- 6.2.1.2.2.1 High penetration capabilities to fuel uptake
- 6.2.1.2.3 Formaldehyde sterilizers
- 6.2.1.2.3.1 Potent antimicrobial properties to aid adoption
- 6.2.1.2.4 Other low-temperature sterilization equipment
- 6.2.1.3 Radiation sterilizers
- 6.2.1.3.1 Utilization across pharmaceutical & biopharmaceutical sectors for vaccines & biologics to drive market
- 6.2.2 CONTRACT STERILIZATION SERVICES
- 6.2.2.1 EtO sterilization services
- 6.2.2.1.1 Expanding applications across medical device sterilization and life science industry to fuel market
- 6.2.2.2 Gamma sterilization services
- 6.2.2.2.1 Minimal chemical residue and ability to penetrate dense materials to fuel uptake
- 6.2.2.3 E-beam sterilization services
- 6.2.2.3.1 Rapid processing and precise control to boost market
- 6.2.2.4 Steam sterilization services
- 6.2.2.4.1 Standard method with optimal efficiency to drive market
- 6.2.2.5 Other contract sterilization services
- 6.3 STERILIZATION ACCESSORIES
- 6.3.1 STERILIZATION INDICATORS
- 6.3.1.1 Chemical indicators
- 6.3.1.1.1 Low cost of chemical indicators to aid adoption
- 6.3.1.2 Biological indicators
- 6.3.1.2.1 Efficacy of biological indicators to drive demand
- 6.3.1.3 Sterilization pouches
- 6.3.1.3.1 Sterility maintenance with time duration to aid adoption
- 6.3.1.4 Sterilization lubricants
- 6.3.1.4.1 Prevention of equipment damage to support market growth
- 6.3.2 OTHER STERILIZATION ACCESSORIES
- 6.4 STERILIZATION CONSUMABLES
- 6.4.1 INCREASING DEMAND FOR STERILANTS IN FOOD & MEDICAL DEVICE INDUSTRIES TO SUPPORT MARKET GROWTH
- 6.5 CLEANING & DISINFECTION PRODUCTS
- 6.5.1 DISINFECTANTS
- 6.5.1.1 Disinfectants, by product type
- 6.5.1.1.1 Hand disinfectants
- 6.5.1.1.1.1 Rising awareness about health & hygiene to boost market
- 6.5.1.1.2 Surface disinfectants
- 6.5.1.1.2.1 Increasing prevalence of HAIs to fuel market
- 6.5.1.1.3 Skin disinfectants
- 6.5.1.1.3.1 Increasing incidence of infectious diseases to fuel market
- 6.5.1.1.4 Instrument disinfectants
- 6.5.1.1.4.1 Growing number of surgical procedures to boost demand
- 6.5.1.2 Disinfectants, by formulation
- 6.5.1.2.1 Disinfectant wipes
- 6.5.1.2.1.1 Easy accessibility to support market growth
- 6.5.1.2.2 Liquid disinfectants
- 6.5.1.2.2.1 Effective utilization and high affordability to propel market
- 6.5.1.2.3 Disinfectant sprays
- 6.5.1.2.3.1 Increasing usage of antimicrobial control measures to fuel demand
- 6.5.1.3 Disinfectants, by EPA classification
- 6.5.1.3.1 Low-level disinfectants
- 6.5.1.3.1.1 Effective elimination of vegetative bacteria and most viruses to boost demand
- 6.5.1.3.2 Intermediate-level disinfectants
- 6.5.1.3.2.1 Applications across dentistry and environmental monitoring to boost demand
- 6.5.1.3.3 High-level disinfectants
- 6.5.1.3.3.1 Sterilization of medical devices and semi-critical instruments across clinical settings to propel uptake
- 6.5.2 CLEANING & DISINFECTION EQUIPMENT
- 6.5.2.1 Washer disinfectors
- 6.5.2.1.1 Utilization of high-pressure water jets and detergents for disinfection to fuel market
- 6.5.2.2 Flusher disinfectors
- 6.5.2.2.1 Innovative product launches to boost demand
- 6.5.2.3 UV-ray disinfectors
- 6.5.2.3.1 Elimination of plethora of viruses, bacteria, and fungi to propel market
- 6.5.2.4 Ultrasonic cleaners
- 6.5.2.4.1 Utilization of high-frequency sound waves for microscopic dirt clearance to aid adoption
- 6.5.2.5 Other cleaning & disinfection equipment
- 6.5.3 LUBRICANTS & CLEANING SOLUTIONS
- 6.5.3.1 Utilization for disinfection of reprocessing instruments to drive market
- 6.5.4 DISINFECTION & CLEANING ACCESSORIES
- 6.5.4.1 Stringent regulatory standards to support market growth
- 6.6 PROTECTIVE BARRIERS
- 6.6.1 MEDICAL NONWOVENS
- 6.6.1.1 Face masks
- 6.6.1.1.1 Increasing prevalence of respiratory diseases to drive market
- 6.6.1.2 Surgical gowns
- 6.6.1.2.1 Growing awareness about infection control to fuel market
- 6.6.1.3 Surgical drapes
- 6.6.1.3.1 Prevention of microorganism transfer from non-sterile surfaces to fuel uptake
- 6.6.2 COVERS & CLOSURES
- 6.6.2.1 Growing focus on food safety to fuel demand
- 6.6.3 GOGGLES
- 6.6.3.1 Increasing use of protective gear in research laboratories to support market growth
- 6.6.4 GLOVES
- 6.6.4.1 Growing concerns related to personnel safety to fuel uptake
- 6.7 ENDOSCOPE REPROCESSING PRODUCTS
- 6.7.1 ENDOSCOPE REPROCESSING CONSUMABLES
- 6.7.1.1 Rising number of endoscope procedures to fuel uptake
- 6.7.2 ENDOSCOPE REPROCESSING EQUIPMENT
- 6.7.2.1 Automated endoscope reprocessors
- 6.7.2.1.1 Growing impact of automated endoscope reprocessors on healthcare expansion to accelerate growth
- 6.7.2.2 Endoscope drying, storage, and transport systems
- 6.7.2.2.1 Need for patient safety and efficient reprocessing workflow to accelerate growth
- 6.7.3 ENDOSCOPE TRACKING SOLUTIONS
- 6.7.3.1 Improved traceability and supervision to foster growth
- 6.8 OTHER INFECTION CONTROL PRODUCTS
7 INFECTION CONTROL MARKET, BY END USER
- 7.1 INTRODUCTION
- 7.2 HOSPITALS & CLINICS
- 7.2.1 STRINGENT CLEANLINESS PROTOCOLS FOR RESTRICTION OF HAIS TO PROPEL MARKET
- 7.3 MEDICAL DEVICE COMPANIES
- 7.3.1 RISING TECHNOLOGICAL INNOVATIONS IN INFECTION CONTROL PRODUCTS TO DRIVE MARKET
- 7.4 PHARMACEUTICAL COMPANIES
- 7.4.1 GROWING NEED FOR SAFETY ASSURANCE AND REGULATORY APPROVALS TO BOOST MARKET
- 7.5 LIFE SCIENCE INDUSTRY
- 7.5.1 INCREASING FOCUS ON CLINICAL RESEARCH INITIATIVES TO FUEL MARKET
- 7.6 FOOD INDUSTRY
- 7.6.1 RISING INCIDENCE OF FOODBORNE DISEASES TO SUPPORT MARKET GROWTH
- 7.7 OTHER END USERS
8 INFECTION CONTROL MARKET, BY REGION
- 8.1 INTRODUCTION
- 8.2 NORTH AMERICA
- 8.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 8.2.2 US
- 8.2.2.1 Rising prevalence of healthcare-associated infections (HAIs) to drive market
- 8.2.3 CANADA
- 8.2.3.1 Rising geriatric population to support market growth
- 8.3 EUROPE
- 8.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 8.3.2 GERMANY
- 8.3.2.1 Growing adoption of hospital disinfection & surveillance systems to drive market
- 8.3.3 UK
- 8.3.3.1 High prevalence of HAIs to drive market
- 8.3.4 FRANCE
- 8.3.4.1 Stringent regulatory guidelines for infection control product commercialization to fuel uptake
- 8.3.5 ITALY
- 8.3.5.1 Increasing establishment of long-term care facilities to boost demand
- 8.3.6 SPAIN
- 8.3.6.1 Increasing prevalence of infectious diseases to fuel market
- 8.3.7 SWITZERLAND
- 8.3.7.1 Heightened burden of CAUTI to drive market
- 8.3.8 REST OF EUROPE
- 8.4 ASIA PACIFIC
- 8.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 8.4.2 JAPAN
- 8.4.2.1 Increasing geriatric population and healthcare expenditure to drive market
- 8.4.3 CHINA
- 8.4.3.1 Rising healthcare spending and increasing prevalence of chronic diseases to drive market
- 8.4.4 INDIA
- 8.4.4.1 Extensive patient population to boost growth
- 8.4.5 AUSTRALIA
- 8.4.5.1 Increasing demand for healthcare services to support market growth
- 8.4.6 SOUTH KOREA
- 8.4.6.1 Increasing government efforts to broaden healthcare coverage to drive market
- 8.4.7 REST OF ASIA PACIFIC
- 8.5 LATIN AMERICA
- 8.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 8.5.2 BRAZIL
- 8.5.2.1 Established pharmaceutical and biotechnology industries to drive market
- 8.5.3 MEXICO
- 8.5.3.1 Increasing prevalence of chronic disorders to aid market growth
- 8.5.4 REST OF LATIN AMERICA
- 8.6 MIDDLE EAST & AFRICA
- 8.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET
- 8.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 8.7 GCC COUNTRIES
- 8.7.1 HIGHER DISPOSABLE INCOMES TO DRIVE DEMAND FOR HEALTHCARE SERVICES
- 8.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
9 COMPETITIVE LANDSCAPE
- 9.1 OVERVIEW
- 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2025
- 9.2.1 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN INFECTION CONTROL MARKET
- 9.3 REVENUE ANALYSIS, 2022-2024
- 9.4 MARKET SHARE ANALYSIS, 2024
- 9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 9.5.1 STARS
- 9.5.2 EMERGING LEADERS
- 9.5.3 PERVASIVE PLAYERS
- 9.5.4 PARTICIPANTS
- 9.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
- 9.5.5.1 Company footprint
- 9.5.5.2 Region footprint
- 9.5.5.3 Product & service footprint
- 9.5.5.4 End-user footprint
- 9.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024
- 9.6.1 PROGRESSIVE COMPANIES
- 9.6.2 RESPONSIVE COMPANIES
- 9.6.3 DYNAMIC COMPANIES
- 9.6.4 STARTING BLOCKS
- 9.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2024
- 9.6.5.1 Detailed list of key startups/SMEs
- 9.6.5.2 Competitive benchmarking of start-ups/SMEs
- 9.7 COMPANY VALUATION & FINANCIAL METRICS
- 9.8 BRAND/PRODUCT COMPARISON
- 9.9 COMPETITIVE SCENARIO
- 9.9.1 PRODUCT LAUNCHES
- 9.9.2 DEALS
- 9.9.3 EXPANSIONS
- 9.9.4 OTHER DEVELOPMENTS
10 COMPANY PROFILES
- 10.1 KEY PLAYERS
- 10.1.1 STERIS
- 10.1.1.1 Business overview
- 10.1.1.2 Products/Services offered
- 10.1.1.3 Recent developments
- 10.1.1.3.1 Product launches & approvals
- 10.1.1.3.2 Deals
- 10.1.1.3.3 Expansions
- 10.1.1.4 MnM view
- 10.1.1.4.1 Right to win
- 10.1.1.4.2 Strategic choices
- 10.1.1.4.3 Weaknesses & competitive threats
- 10.1.2 RECKITT BENCKISER GROUP PLC
- 10.1.2.1 Business overview
- 10.1.2.2 Products/Services offered
- 10.1.2.3 Recent developments
- 10.1.2.3.1 Product launches
- 10.1.2.3.2 Deals
- 10.1.2.4 MnM view
- 10.1.2.4.1 Right to win
- 10.1.2.4.2 Strategic choices
- 10.1.2.4.3 Weaknesses & competitive threats
- 10.1.3 FORTIVE
- 10.1.3.1 Business overview
- 10.1.3.2 Products/Services offered
- 10.1.3.3 MnM view
- 10.1.3.3.1 Right to win
- 10.1.3.3.2 Strategic choices
- 10.1.3.3.3 Weaknesses & competitive threats
- 10.1.4 SOTERA HEALTH
- 10.1.4.1 Business overview
- 10.1.4.2 Products/Services offered
- 10.1.4.3 Recent developments
- 10.1.4.4 MnM view
- 10.1.4.4.1 Right to win
- 10.1.4.4.2 Strategic choices
- 10.1.4.4.3 Weaknesses & competitive threats
- 10.1.5 SOLVENTUM
- 10.1.5.1 Business overview
- 10.1.5.2 Products/Services offered
- 10.1.5.3 Recent developments
- 10.1.5.3.1 Product launches
- 10.1.5.3.2 Other developments
- 10.1.5.4 MnM view
- 10.1.5.4.1 Right to win
- 10.1.5.4.2 Strategic choices
- 10.1.5.4.3 Weaknesses & competitive threats
- 10.1.6 GETINGE AB
- 10.1.6.1 Business overview
- 10.1.6.2 Products/Services offered
- 10.1.6.3 Recent developments
- 10.1.6.3.1 Product launches
- 10.1.6.3.2 Deals
- 10.1.7 ECOLAB, INC.
- 10.1.7.1 Business overview
- 10.1.7.2 Products/Services offered
- 10.1.7.3 Recent developments
- 10.1.7.3.1 Product launches
- 10.1.7.3.2 Deals
- 10.1.8 OLYMPUS CORPORATION
- 10.1.8.1 Business overview
- 10.1.8.2 Products/Services offered
- 10.1.8.3 Recent developments
- 10.1.8.3.1 Product launches
- 10.1.8.3.2 Deals
- 10.1.8.3.3 Expansions
- 10.1.9 ENVISTA
- 10.1.9.1 Business overview
- 10.1.9.2 Products/Services offered
- 10.1.10 PAUL HARTMANN AG
- 10.1.10.1 Business overview
- 10.1.10.2 Products/Services offered
- 10.1.11 B. BRAUN SE
- 10.1.11.1 Business overview
- 10.1.11.2 Products/Services offered
- 10.1.11.3 Recent developments
- 10.1.11.3.1 Other developments
- 10.1.12 KIMBERLY-CLARK CORPORATION
- 10.1.12.1 Business overview
- 10.1.12.2 Products/Services offered
- 10.1.13 CARDINAL HEALTH
- 10.1.13.1 Business overview
- 10.1.13.2 Products/Services offered
- 10.1.13.3 Recent developments
- 10.1.14 PROCTER & GAMBLE
- 10.1.14.1 Business overview
- 10.1.14.2 Products/Services offered
- 10.1.15 THE CLOROX COMPANY
- 10.1.15.1 Business overview
- 10.1.15.2 Products/Services offered
- 10.1.15.3 Recent developments
- 10.1.16 STRYKER CORPORATION
- 10.1.16.1 Business overview
- 10.1.16.2 Products/Services offered
- 10.1.17 HOYA CORPORATION
- 10.1.17.1 Business overview
- 10.1.17.2 Products/Services offered
- 10.1.17.3 Recent developments
- 10.1.18 CONMED CORPORATION
- 10.1.18.1 Business overview
- 10.1.18.2 Products/Services offered
- 10.1.19 FUJIFILM HOLDINGS CORPORATION
- 10.1.19.1 Business overview
- 10.1.19.2 Products/Services offered
- 10.2 OTHER PLAYERS
- 10.2.1 MIELE GROUP (JOINT VENTURE WITH METALL ZUG)
- 10.2.2 MMM GROUP
- 10.2.3 ANTONIO MATACHANA, S.A.
- 10.2.4 PAL INTERNATIONAL
- 10.2.5 SYSTEC GMBH & CO.KG
- 10.2.6 CONTEC, INC.
- 10.2.7 MEDALKAN
- 10.2.8 DR. SCHUMACHER GMBH
- 10.2.9 ULTRAWAVE
- 10.2.10 SCHULKE & MAYR GMBH
- 10.2.11 STERITEK INC.
11 APPENDIX
- 11.1 DISCUSSION GUIDE
- 11.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 11.3 CUSTOMIZATION OPTIONS
- 11.4 RELATED REPORTS
- 11.5 AUTHOR DETAILS